This post has expired! It was posted more than 90 days ago.
<- Back

138458 - Pre-exposure Prophylaxis in General Practice

  • : Online


This Clinical Audit is designed to assist GPs to identify and appropriately manage patients at risk of HIV using the Pre-exposure Proplyaxix (PrEP) combination anti-retroviral medication that was recently listed on the PBS. This audit is an optional activity for GPs participating in 2018 GP Update face to face or online course.

Relevance to General Practice

Prescribing this drug aligns with the government's strategy to eliminate HIV transmission by 2020. 
Daily use of coformulated tenofovir and emtricitabine for HIV pre-exposure prophylaxis (PrEP) by populations at high risk of HIV infection is now recommended in guidelines from the United States, Europe and Australia and globally through the 2015 WHO guidelines. 
Excerpt from ASHM Journal of Virus Eradication: http://viruseradication.com/journal-details/Australasian_Society_for_HIV,_Viral_Hepatitis_and_Sexual_Healt h_Medicine_HIV_pre-exposure_prophylaxis:_clinical_guidelines._Update_April_ 2018/

Learning outcomes
  • Establish a systematic approach to the preventive care of patients engaged in high risk sexual contacts.
  • Outline the principles of prescribing PrEP.
  • Determine a holistic approach to the care of patients at risk of contracting sexually transmissible infections.
  • Identify and interpret clinical resources provided to support prescribing of PrEP.

    138458 - Pre-exposure Prophylaxis in General Practice
    20 hours
    Start Date
    End Date
    CPD Points
    20 hours
    Contact Phone
    Log in into view this field.